
Vistagen Therapeutics, Inc. (VTGN) Q4 2025 Earnings Call Transcript
Vistagen Therapeutics, Inc. (NASDAQ:VTGN) Q4 2025 Earnings Conference Call June 17, 2025 5:00 PM ET Company Participants Cynthia Lynn Anderson – VP & Chief Financial OfficerMark Adrian McPartland – Senior Vice President